46,568 Shares in Oscar Health, Inc. (NYSE:OSCR) Bought by Janney Montgomery Scott LLC

Janney Montgomery Scott LLC bought a new position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 46,568 shares of the company's stock, valued at approximately $988,000.

A number of other large investors have also recently added to or reduced their stakes in OSCR. Assenagon Asset Management S.A. lifted its stake in shares of Oscar Health by 32.9% in the second quarter. Assenagon Asset Management S.A. now owns 2,046,046 shares of the company's stock worth $32,368,000 after buying an additional 507,009 shares during the last quarter. FCG Investment Co acquired a new position in Oscar Health during the 3rd quarter worth $986,000. Jupiter Asset Management Ltd. bought a new stake in Oscar Health during the first quarter valued at about $653,000. Toth Financial Advisory Corp grew its position in shares of Oscar Health by 73,185.7% in the third quarter. Toth Financial Advisory Corp now owns 51,300 shares of the company's stock valued at $1,088,000 after purchasing an additional 51,230 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD increased its stake in shares of Oscar Health by 153.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 3,978,152 shares of the company's stock worth $59,156,000 after purchasing an additional 2,409,160 shares during the period. Institutional investors own 75.70% of the company's stock.

Analyst Ratings Changes

Several analysts recently weighed in on the company. Bank of America downgraded Oscar Health from a "neutral" rating to an "underperform" rating and decreased their target price for the company from $21.00 to $13.50 in a research note on Wednesday, November 6th. Piper Sandler reissued an "overweight" rating and issued a $28.00 price objective on shares of Oscar Health in a research report on Tuesday, September 10th. Finally, UBS Group began coverage on shares of Oscar Health in a research report on Monday, October 7th. They set a "neutral" rating and a $23.00 target price on the stock. One investment analyst has rated the stock with a sell rating, two have given a hold rating, four have given a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $22.93.

Oscar Health Trading Down 3.7 %

OSCR opened at $14.87 on Friday. Oscar Health, Inc. has a 12 month low of $6.93 and a 12 month high of $23.79. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.91 and a current ratio of 0.73. The company has a fifty day simple moving average of $18.20 and a 200 day simple moving average of $18.27.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.20) by ($0.02). Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The firm had revenue of $2.42 billion during the quarter, compared to analyst estimates of $2.33 billion. During the same period in the prior year, the business posted ($0.29) EPS. The firm's quarterly revenue was up 68.3% compared to the same quarter last year. On average, analysts predict that Oscar Health, Inc. will post -0.01 EPS for the current fiscal year.

Insider Activity at Oscar Health

In other Oscar Health news, CAO Victoria Baltrus sold 4,226 shares of the stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $76,025.74. Following the transaction, the chief accounting officer now directly owns 140,648 shares of the company's stock, valued at $2,530,257.52. This represents a 2.92 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Mario Schlosser sold 3,198 shares of the stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total value of $57,532.02. Following the transaction, the insider now owns 76,982 shares in the company, valued at approximately $1,384,906.18. This trade represents a 3.99 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders bought 1,055,478 shares of company stock valued at $14,432,852 and sold 169,569 shares valued at $3,007,069. 25.11% of the stock is owned by company insiders.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.